ArticleFrontiers in pharmacology2022

Quantitative comparison of the efficacies and safety profiles of three first-line non-platinum chemotherapy regimens for advanced non-small cell lung cancer.

Qian-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.